Concepedia

John Liddle

JL

Statistics

Publications

81

Citations

5.2K

H-Index

35

Active since

1973

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

Age UK

United States Department of Health and Human Services

GlaxoSmithKline (United States)

University of Edinburgh

John Liddle is an author at GlaxoSmithKline (United Kingdom) specializing in pharmacology, pharmacy, and medicinal chemistry.

ORCID

Publications per year

1973–2023

81

Publications

81

A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response

Laurens Kruidenier, Chun‐wa Chung, Zhongjun Cheng et al. · Nature · 2012 · 958 citations · Full text

, , +14

Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation

Huw D. Lewis, John Liddle, Jim Coote et al. · Nature Chemical Biology · 2015 · 760 citations · Full text

, , +2

3-(1′,1′-Dimethylbutyl)-1-deoxy-Δ8-THC and related compounds: synthesis of selective ligands for the CB2 receptor

John W. Huffman, John Liddle, Shu Yu et al. · Bioorganic & Medicinal Chemistry · 1999 · 287 citations

, , +13

EPIDEMIC KEPONE POISONING IN CHEMICAL WORKERS

Shanklin B. Cannon, James Veazey, Robert S. Jackson et al. · American Journal of Epidemiology · 1978 · 211 citations

, , +17

Epidemic Lead Absorption near an Ore Smelter

Philip J. Landrigan, Stephen H. Gehlbach, Bernard F. Rosenblum et al. · New England Journal of Medicine · 1975 · 188 citations

, , +17

1–5 of 81